"Okay, okay. Hahaha!"
Ren Bin, the general manager of Daxia Intelligent Manufacturing, let out a hearty laugh after hanging up the phone.
He looked for the R&D director with a radiant face: "Sanqing is generally very satisfied with our sequencer, but they asked to send people to optimize the algorithm and customize the kit to improve the data accuracy. You can find a few technical backbones and Send them over quickly."
"We must show that we value our customers. We will do whatever our customers say!"
The R&D director nodded in agreement and quickly dispatched troops and generals when he returned and sent people to station in Sanqing.
A week later, Ren Bin was in the office with his legs crossed, drinking tea and watching the news.
Suddenly, the R&D director rushed in: "Mr. Ren, it's done. Under the guidance of Sanqing, after improving the algorithm, the data accuracy has improved a lot, reaching 99.9%, the same as Illumina. Sanqing said we will continue to optimize If we continue, this value can be improved further.”
Ren Bin was overjoyed: "Is it true or false? Have you verified it? Take me over and have a look."
After coming to the R&D department and seeing the operating conditions of the machine, he was overjoyed and walked around the site excitedly.
"That's great. It's really not a bad thing to have Sanqing's golden thigh."
"Quick, don't we have a batch of goods to be sent to Camel Country soon? Hurry up and update the firmware and upgrade the new algorithm."
The R&D director hesitated: "This batch of goods has been packed and will be shipped tomorrow. Unpacking it again may delay the shipping date."
Ren Bin Zhan Jin Jietie said: "Tear it down, tear it all apart, be sure to upgrade it to the latest firmware. Do it at all costs."
"Over in Camel Country, as long as they are told that the equipment has been upgraded with new firmware and the data accuracy has reached a new level, it will definitely save costs and shorten the test time. The customers will definitely be very happy and will not care about the delivery time. It’s been delayed for a few days.”
"Mr. Ren is brilliant!" the R&D Director praised.
Soon, a new batch of sequencers was packed in containers and traveled across the ocean to Camel Country.
After learning the new news, the biologists in the Camel Country performed a sequencing check on the new machine with suspicion, and the data results surprised them.
The accuracy has indeed been greatly improved. It is very difficult to improve a value above 95%. Unexpectedly, the highest accuracy of 99.9% was directly mentioned this time.
This eliminates the need for multiple sequencing and can produce results in one go, which not only reduces time but also greatly saves costs.
The person in charge of the Camel Country Human Gene Bank was very happy. They had originally criticized Daxia's sequencer. They felt that although the cost was low, it was a bit troublesome to use and the accuracy was not very high. They were hesitant to continue purchasing it.
Now I saw that the upgraded version was so effective that I immediately signed a batch of new contracts with Daxia Intelligent Manufacturing.
The reputation of Daxia Intelligent Manufacturing spread instantly in the desert country.
Since the release of the complete human genome, all countries with some strength are now ready to establish their own national race gene pool.
This has undoubtedly greatly increased the global sales of gene sequencers.
In addition to big tycoons like the Camel Country, there are also many other countries in the desert that want to build their own human gene pools.
After visiting the Camel Country, they found that the machines made by Daxia Intelligent Manufacturing were indeed cheap, easy to use, and highly accurate, so they all placed orders one after another.
Daxia Intelligent Manufacturing became famous in a short period of time, sold more than a hundred machines, and overseas sales increased significantly.
The most important thing is that their reputation in third world countries has been established. Customers no longer have only Illumina as a choice, but have also considered Daxia Intelligent Manufacturing. If this continues, there will only be more and more customers in the future. .
In addition, Daxia Intelligent Manufacturing announced a cooperation plan with Sanqing, and announced the technical parameters of the latest machine, as well as sequencing data. As a result, its reputation has skyrocketed, and its domestic sales have also continued to increase.
During this time, in the sales department of Daxia Zhizao, the phone rings kept ringing one after another, and countless inquiry emails flew in like snow flakes.
The sales managers were rude when they answered the phone. They were all thirsty when talking, but they were as excited as if they had been given a shot of chicken blood.
General Manager Ren Bin was even more proud. He quickly updated the financial statements. Not only did the revenue surge, but the number of domestic and foreign customers also increased a lot. All the data were very good.
Subsequently, he resubmitted his application for listing on the Science and Technology Innovation Board.
This time, the listing application was passed smoothly. Daxia Zhizao was finally taken away by the golden thigh, and the IPO was successful.
As soon as it was listed, the stock price rose rapidly from 20 yuan, doubled several times, and only stopped when it approached the 100 mark.
For a new stock, Daxia Zhizao has undoubtedly delivered an excellent result.
Such performance also represents the optimism of capital and the confidence of the market.
As soon as the news came out, Miner's stock price plummeted.
Between the decline and the rise, some people are really happy and some are sad.
At the same time, Daxia Intelligent Manufacturing’s competitor, Illumina headquarters in California, Eagle Country.
In a spacious conference room, senior executives gathered together with ugly expressions on their faces.
CEO Dr. Anthony, who is also one of the founders of the company, looked at everyone with a gloomy look on his face.
"The successful listing of Daxia Intelligent Manufacturing is not good news. Now, it has become a strong opponent and is pressing hard to attack us."
"Although their overseas market share is still very low and they cannot pose a threat to us, in China, we have already lost 40% of the market. If this continues, we are likely to lose more."
"We cannot give up on this market in China easily. What suggestions do you have?"
An executive said: "Patents, patents, patents. I have seen Daxia's new machine data, and the gap with us is not big. It is difficult to put aside our opponents in the short term in terms of technology, and we have no advantage in terms of cost." , the only way forward is to go all out and make a big fuss about patents.”
"Daxia Intelligent Manufacturing has lawsuits against us in 12 countries around the world. We should do our best to make a fuss about this, try our best to drag them down, strive to win the patent lawsuit, and drive them out of these markets."
"Even in China, we cannot give up and fight more patent lawsuits. This is where our advantage lies."
Dr. Anthony nodded approvingly: "Excellent, that's exactly what I thought."
He looked around and said slowly: "Do you have any other suggestions?"
Another executive spoke eloquently: "We need to do our best to expand upstream and downstream business. Not only should we be an upstream instrument manufacturer, but we should also acquire companies to enter the midstream and downstream markets, thereby forming a full industry chain."
"In this way, not only will our moat be deeper and wider than our competitors, but our midstream and downstream businesses will also gain cost advantages."
An executive retorted: "We have entered the downstream early cancer screening market and acquired the 'Holy Grail' company, but it turns out that this move is not beneficial to the company, and the stock price has fallen by more than 20%."
"We are famous for our DNA sequencers, but we have been struggling to make clinical investments. Isn't this taking business away from our own customers? Is this really good for the company?"
"If we compete with our own customers in the downstream market, will customers still buy our equipment? They will just abandon us faster and buy equipment from competitors."
As soon as these words came out, someone immediately objected: "But the market for downstream business is much larger. The market for sequencers is only a few billion dollars, but the market for early cancer screening can reach hundreds of billions of dollars. This is a twenty-fold difference."
Dr. Anthony nodded: "Yes, we already have a monopoly in the sequencer market, and our development has come to an end. The right direction is to develop into a larger downstream market. There is no doubt about this."
He scanned the audience with his penetrating eyes and came to a conclusion: "Then let's start with the patents to fight back, and then the costs should be appropriately reduced to win more customers."
"In the future, the battlefield between us and Daxia Intelligent Manufacturing will not only be sequencers, but also the field of genetic testing."
"This is a cruel war. Although the opponent is still very weak, it is backed by a powerful country and has a vast market. It cannot be underestimated."
